Russian scientists plan to begin clinical trials in just a couple of weeks on a vaccine to fight the book coronavirus, the health minister has been quoted as saying Saturday as government approved the nation’s first anti-COVID-19 medication.
“The evaluations are underway and we intend to begin clinical trials in the following two weeks,” Health Minister Mikhail Murashko was quoted as saying from the TASS news agency. He said volunteers were chosen to share in the trials.
Drugmakers globally are rushing to develop vaccines and treatments for the virus which has caused 364,000 deaths globally.
The Russian Direct Investment Fund stated the Health Ministry had accepted Avifavir for the treatment of COVID-19.
It was created on the grounds of a drug known called favipiravir.
RDIF stated Avifavir had proved highly effective in treating patients using coronavirus at the very first period of its clinical trials.
There are now about 10 coronavirus vaccines being tested in people and experts have predicted a safe and effective vaccine may take 12 to 18 weeks from the beginning of development.
Maksyutov stated vaccine trials animals were successful.
Russia on Saturday reported 181 deaths in the coronavirus in the previous 24 hours down from the listing 232 deaths that the past day – bringing the national death toll to 4,555.
Officials stated 8,952 new infections were confirmed, bringing the federal tally into 396,575 cases.